Regulatory Resources

Clinical guidelines, MDCG guidance, FDA guidance, standards, and compliance tools

Home/Resources
All Categories
American Guidelines 221 Annex XVI Products 3 Borderline and Classification 5 Brazil (ANVISA) 1 Cardiology & Vascular 19 Cardiology & Vascular 47 China (NMPA) 1 Class I Devices 1 Clinical Investigation and Evaluation 17 Dermatology & Venereology 12 Dermatology & Venereology 7 Endocrinology, Diabetes & Metabolism 19 Endocrinology, Diabetes & Metabolism 20 EU 3 EU Regulation 2 EUDAMED 2 European Guidelines 510 Eye, ENT & Neurosensory 5 Eye, ENT & Neurosensory 7 FDA Guidance 106 Gastroenterology & Hepatology 40 Gastroenterology & Hepatology 47 Imaging & Radiology 6 Imaging & Radiology 5 IMDRF Documents 115 India (CDSCO) 1 Infectious Diseases & Microbiology 31 Infectious Diseases & Microbiology 13 Internal Medicine & Emergency 14 Internal Medicine & Emergency 4 IVDR 2 Japan (PMDA) 1 MDCG Guidance 54 MDR 8 Medical Guidelines & Recommendations 731 Medical Technology & Engineering 0 Medical Technology & Engineering 0 NB White Papers 15 Neurology & Neurosurgery 56 Neurology & Neurosurgery 12 New Technologies 7 Notified Bodies 4 Oncology & Haematology 74 Oncology & Haematology 33 Other / Transition 5 Paediatrics 16 Paediatrics 6 Post-Market Surveillance and Vigilance 5 Public Health & Primary Care 39 Public Health & Primary Care 8 Regulations 17 Rehabilitation & Geriatrics 4 Rehabilitation & Geriatrics 15 Respiratory & Intensive Care 29 Respiratory & Intensive Care 8 Rheumatology & Immunology 29 Rheumatology & Immunology 11 South Korea (MFDS) 1 Standards 51 Surgery & Orthopaedics 5 Surgery & Orthopaedics 30 Team NB Documents 50 UDI 4 UK (MHRA) 1 Umbrella & Cross-Cutting 8 Umbrella & Cross-Cutting 0 US (FDA) 8 Women's Health & Obstetrics 33 Women's Health & Obstetrics 12
22 resources

Brazil meeting outcome statement

IMDRF Outcome statement IMDRF Documents

Outcome statement published by IMDRF.

Download PDF

Brussels meeting outcome statement

IMDRF Outcome statement 2013-11-12 IMDRF Documents

Outcome statement published 2013 by IMDRF.

Download PDF

Balancing Premarket and Postmarket Data Collection for Devices Subject to Premarket Approval

FDA Guidance 2015-04-01 FDA Guidance

Final FDA guidance on pma. Published 2015 by CDRH/CBER.

Download PDF

Benefit-Risk Factors to Consider When Determining Substantial Equivalence in 510(k) Submissions

FDA Guidance 2018-09-01 FDA Guidance

Final FDA guidance on 510(k). Published 2018 by CDRH/CBER.

Download PDF

Best Practices for Selecting a Predicate Device to Support a 510(k) Submission

FDA Guidance 2023-09-01 FDA Guidance

Draft FDA guidance on 510(k). Published 2023 by CDRH/CBER.

Download PDF

Breakthrough Devices Program

FDA Guidance 2023-09-01 FDA Guidance

Final FDA guidance on breakthrough devices. Published 2023 by CDRH/CBER.

Download PDF

Biocompatibility Testing of Medical Devices — ASCA Program

FDA Guidance 2024-09-01 FDA Guidance

Draft FDA guidance on biocompatibility. Published 2024 by CDRH/CBER.

Download PDF

Basic Safety and Essential Performance of Medical Electrical Equipment — ASCA Program

FDA Guidance 2024-09-01 FDA Guidance

Draft FDA guidance on standards & conformity. Published 2024 by CDRH/CBER.

Download PDF

BSI — Post-Market Surveillance and Vigilance Under EU MDR

NB White Paper 2023-11-01 MDR NB White Papers
Download PDF

BSI — Software as a Medical Device (SaMD) Classification and Certification

NB White Paper 2023-06-01 MDR NB White Papers
Download PDF
Loading more resources…
Scroll to Top